High-grade heart block associated with ibrutinib therapy

HeartRhythm Case Rep. 2021 Mar 19;7(6):391-394. doi: 10.1016/j.hrcr.2021.03.013. eCollection 2021 Jun.

Alexander R Vartanov¹, Benjamin L Lampson^{1

2}, Eric D Jacobsen^{1

2}, Edwin P Alyea³, Javid J Moslehi⁴, Jennifer R Brown^{1

2}

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
² Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
⁴ Department of Medicine, Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, Tennessee.

No abstract available

Keywords: Arrhythmia; BTK inhibitor; CLL; Cardio-oncology; Conduction disorder.

Publication types